Holocene Advisors’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $203M | Sell |
2,016,806
-9,616
| -0.5% | -$968K | 0.5% | 61 |
|
|
2025
Q1 | $155M | Buy |
2,026,422
+1,338,710
| +195% | +$102M | 0.45% | 62 |
|
|
2024
Q4 | $47.5M | Buy |
+687,712
| New | +$47.5M | 0.15% | 162 |
|
|
2024
Q1 | – | Sell |
-1,614,862
| Closed | -$50M | – | 782 |
|
|
2023
Q4 | $50M | Sell |
1,614,862
-193,626
| -11% | -$6M | 0.2% | 150 |
|
|
2023
Q3 | $45.7M | Sell |
1,808,488
-274,390
| -13% | -$6.93M | 0.2% | 142 |
|
|
2023
Q2 | $43.9M | Sell |
2,082,878
-132,269
| -6% | -$2.79M | 0.19% | 142 |
|
|
2023
Q1 | $37.8M | Buy |
2,215,147
+76,280
| +4% | +$1.3M | 0.19% | 149 |
|
|
2022
Q4 | $42.7M | Buy |
2,138,867
+408,359
| +24% | +$8.16M | 0.26% | 118 |
|
|
2022
Q3 | $37.3M | Sell |
1,730,508
-1,163,314
| -40% | -$25.1M | 0.24% | 124 |
|
|
2022
Q2 | $57.1M | Buy |
2,893,822
+150,243
| +5% | +$2.96M | 0.34% | 101 |
|
|
2022
Q1 | $64.5M | Buy |
2,743,579
+606,993
| +28% | +$14.3M | 0.34% | 97 |
|
|
2021
Q4 | $58.2M | Sell |
2,136,586
-50,689
| -2% | -$1.38M | 0.3% | 107 |
|
|
2021
Q3 | $60.2M | Sell |
2,187,275
-314,004
| -13% | -$8.65M | 0.33% | 92 |
|
|
2021
Q2 | $71.2M | Buy |
2,501,279
+723,666
| +41% | +$20.6M | 0.4% | 80 |
|
|
2021
Q1 | $60.5M | Buy |
1,777,613
+849,522
| +92% | +$28.9M | 0.38% | 78 |
|
|
2020
Q4 | $30.9M | Sell |
928,091
-210,131
| -18% | -$7M | 0.19% | 151 |
|
|
2020
Q3 | $36.6M | Buy |
1,138,222
+31,389
| +3% | +$1.01M | 0.28% | 107 |
|
|
2020
Q2 | $30.5M | Buy |
1,106,833
+245,920
| +29% | +$6.77M | 0.27% | 102 |
|
|
2020
Q1 | $13.8M | Buy |
+860,913
| New | +$13.8M | 0.15% | 142 |
|